J&J CFO Wolk on First-Quarter, Vaccine Guidance, Forecast

The transcript covers Johnson & Johnson's performance, highlighting growth in Med Tech and pharmaceuticals, and challenges in consumer health. It discusses the impact of foreign exchange on financials, adjustments in vaccine demand, and global risks like China's lockdowns and the Ukraine war. The resilience of healthcare during potential recessions is also explored.

What segments contributed to the growth of Johnson and Johnson as mentioned in the earnings call?

How has the foreign exchange (FX) impacted Johnson and Johnson's financial performance in the quarter?

What challenges related to the vaccine supply were discussed during the earnings call?

What is Johnson and Johnson's outlook on the demand for vaccines in the future?

What are the anticipated impacts of the war in Ukraine on Johnson and Johnson's operations?

In what ways does Johnson and Johnson believe healthcare is prioritized during economic downturns?

How does Johnson and Johnson plan to address the inflationary pressures mentioned in the earnings call?